Convex Clinical Research Center was designed and built to address all the needs of the clinical research process. With over 40 experienced clinical investigators our Clinical research center with phase 1 unit offer an excellent approach to early phase research. Convex phase 1 unit is designed and built to address all the needs of the clinical research process and to ensure quality medical care and safety standards. Open 24/7, it is custom-designed facility and it is focused on pharmacokinetic studies on healthy volunteers. Our dedicated team of pharmacologists and early phase clinical research team perform phase 1 studies on patient population with a spectrum of diseases. Before each study is initiated we ensure all protocol requirements are followed and Convex Phase 1 unit is in compliance with the appropriate guidelines and regulations. The Phase 1 unit, centrally located in Sofia city, allowing Convex dedicated staff to progress within the process of recruitment and retention of volunteers and to constantly develop a database of study subjects for multiple types of clinical trials. Our phase 1unit is constructed in a way to facilitate phase 1 researchers to conduct studies for a new drug or treatment in a small group of people and to evaluate its safety, determine a safe dosage range and/or identify side effects. Our expertise includes First-In-Man (FIM) studies, escalating dose studies, interaction studies, PK/PD studies, bioequivalence studies, and early phase studies. Convex clinical research institution with Phase 1 unit is designed and equipped to ensure compliance and safety. Our facilities include:
